Your browser doesn't support javascript.
loading
Lactobacillus paracasei KBL382 administration attenuates atopic dermatitis by modulating immune response and gut microbiota.
Kim, Woon-Ki; Jang, You Jin; Han, Dae Hee; Jeon, Kyungchan; Lee, Cheonghoon; Han, Hyuk Seung; Ko, GwangPyo.
Afiliación
  • Kim WK; Graduate School of Public Health, Seoul National University , Seoul, Republic of Korea.
  • Jang YJ; Institute of Health and Environment, Seoul National University , Seoul, Republic of Korea.
  • Han DH; Graduate School of Public Health, Seoul National University , Seoul, Republic of Korea.
  • Jeon K; Graduate School of Public Health, Seoul National University , Seoul, Republic of Korea.
  • Lee C; Graduate School of Public Health, Seoul National University , Seoul, Republic of Korea.
  • Han HS; Graduate School of Public Health, Seoul National University , Seoul, Republic of Korea.
  • Ko G; Institute of Health and Environment, Seoul National University , Seoul, Republic of Korea.
Gut Microbes ; 12(1): 1-14, 2020 11 09.
Article en En | MEDLINE | ID: mdl-33016202

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Probióticos / Dermatitis Atópica / Inmunomodulación / Microbioma Gastrointestinal / Lacticaseibacillus paracasei Límite: Animals Idioma: En Revista: Gut Microbes Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Probióticos / Dermatitis Atópica / Inmunomodulación / Microbioma Gastrointestinal / Lacticaseibacillus paracasei Límite: Animals Idioma: En Revista: Gut Microbes Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos